title: Oxytocin selectively moderates negative cognitive appraisals in high trait anxious males.
abstract: The mammalian neuropeptide oxytocin has well-characterized effects in facilitating prosocial and affiliative behavior. Additionally, oxytocin decreases physiological and behavioral responses to social stress. In the present study we investigated the effects of oxytocin on cognitive appraisals after a naturalistic social stress task in healthy male students. In a randomized, double-blind, placebo-controlled trial, 48 participants self-administered either an oxytocin or placebo nasal spray and, following a wait period, completed an impromptu speech task. Eye gaze to a pre-recorded video of an audience displayed during the task was simultaneously collected. After the speech, participants completed questionnaires assessing negative cognitive beliefs about speech performance. Whilst there was no overall effect of oxytocin compared to placebo on either eye gaze or questionnaire measures, there were significant positive correlations between trait levels of anxiety and negative self-appraisals following the speech. Exploratory analyses revealed that whilst higher trait anxiety was associated with increasingly poorer perceptions of speech performance in the placebo group, this relationship was not found in participants administered oxytocin. These results provide preliminary evidence to suggest that oxytocin may reduce negative cognitive self-appraisals in high trait anxious males. It adds to a growing body of evidence that oxytocin seems to attenuate negative cognitive responses to stress in anxious individuals.
authors.affiliation: Brain & Mind Research Institute, University of Sydney, 100 Mallett St, Camperdown, NSW 2050, Australia.
authors.forename: Gail A
authors.initials: GA
authors.lastname: Alvares
authors.forename: Nigel T M
authors.initials: NT
authors.lastname: Chen
authors.forename: Bernard W
authors.initials: BW
authors.lastname: Balleine
authors.forename: Ian B
authors.initials: IB
authors.lastname: Hickie
authors.forename: Adam J
authors.initials: AJ
authors.lastname: Guastella
mesh_terms: D000281:Administration, Intranasal; D000328:Adult; D000339:Affect; D001007:Anxiety / Q000523:psychology; D003071:Cognition / Q000187:drug effects*; D059026:Diagnostic Self Evaluation; D004311:Double-Blind Method; D005133:Eye Movements / Q000187:drug effects*; D006801:Humans; D008297:Male; D010121:Oxytocin / Q000008:administration & dosage / Q000494:pharmacology*; D010555:Personality Inventory / Q000706:statistics & numerical data; D010775:Photic Stimulation / Q000379:methods; D011597:Psychomotor Performance / Q000187:drug effects; D014796:Visual Perception / Q000187:drug effects
chemical_list: D010121:Oxytocin